Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK2330672 for pruritus in primary biliary cholangitis
2016-002416-41Phase 2Completed
- Sponsor
- GSK
- Start
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in primary biliary cholangitis (PBC) comparing GSK2330672 with Placebo (2 arms). Primary endpoint: Mean change from Baseline at Week 16 in the Mean Worst Daily Itch Score. Started Dec 2016; status: completed.
02
Drugs
linerixibat
03
Conditions
primary biliary cholangitis (PBC)
Beyond the preview
Go deeper on 2016-002416-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-002416-41.